Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results

Abstract Purpose To investigate whether progestin‐primed ovarian stimulation (PPOS) with chlormadinone acetate (CMA) adversely affects clinical results and neonatal outcomes, or causes congenital deformities. Methods This retrospective study was conducted at private IVF clinic from November 2018 to...

Full description

Bibliographic Details
Main Authors: Sena Shibasaki, Hiromitsu Hattori, Masae Koizumi, Satoko Nagaura, Mayumi Toya, Hideki Igarashi, Koichi Kyono
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Reproductive Medicine and Biology
Subjects:
chlormadinone acetate
congenital abnormality
cryopreservation
newborn infant
ovulation induction
Online Access:https://doi.org/10.1002/rmb2.12519

Internet

https://doi.org/10.1002/rmb2.12519

Similar Items